Part 12/13:
Indian companies aim to collaborate with global vaccine manufacturers to meet international demand. As new vaccines—like those from Oxford-AstraZeneca, Sputnik V, Johnson & Johnson, and Novavax—reach approval, India’s already substantial vaccine infrastructure will likely further expand, reinforcing its role as a crucial supplier in the global fight against COVID-19.
Concluding Outlook: Hopes, Challenges, and the Road Ahead
The global community stands at a pivotal moment. The development of digital vaccine passports and the rapid scaling of vaccine production could significantly accelerate international travel and economic recovery. Nevertheless, obstacles such as vaccine equity, privacy concerns, and logistical implementation challenges temper optimism.